Guangzhou Changsheng Guda Culture Development Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Changsheng Guda Culture Development Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LINHUANXILE. The owner is based in Guangzhou.
AF88, Room 1829, No. 518,
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Changsheng Guda Culture Development Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Guangzhou Changsheng Guda Culture Development Co., Ltd. have?
Guangzhou Changsheng Guda Culture Development Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Guangzhou Changsheng Guda Culture Development Co., Ltd. file in?
Guangzhou Changsheng Guda Culture Development Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Guangzhou Changsheng Guda Culture Development Co., Ltd.'s most well-known trademarks?
Guangzhou Changsheng Guda Culture Development Co., Ltd.'s registered trademark portfolio includes well-known marks such as LINHUANXILE. These are among 1 currently registered trademark in the portfolio.
What is Guangzhou Changsheng Guda Culture Development Co., Ltd.'s trademark registration success rate?
Guangzhou Changsheng Guda Culture Development Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.